D. E. Shaw & Co., Inc. Qiagen N.V. Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$35.55 - $43.57 $2.78 Million - $3.41 Million	-78,317 Reduced 25.45%	229,449 $9.96 Million
Q3 2023 Nov 14, 2023	BUY	$39.13 - $47.24 $2.65 Million - $3.2 Million	67,660 Added 28.18%	307,766 $12.5 Million
Q2 2023 Aug 14, 2023	SELL	$43.93 - $46.76 $9.41 Million - $10 Million	-214,161 Reduced 47.14%	240,106 $10.8 Million
Q1 2023 May 15, 2023	BUY	$45.29 - $50.76 $2.9 Million - $3.25 Million	63,950 Added 16.38%	454,267 $20.9 Million
Q4 2022 Feb 14, 2023	BUY	$41.91 - $50.48 $10.9 Million - $13.2 Million	261,102 Added 202.07%	390,317 $19.5 Million
Q3 2022 Nov 14, 2022	SELL	$40.9 - $50.42 $575,626 - $709,611	-14,074 Reduced 9.82%	129,215 $5.37 Million
Q2 2022 Aug 15, 2022	SELL	$42.98 - $49.77 $4.62 Million - $5.35 Million	-107,401 Reduced 42.84%	143,289 $6.75 Million
Q1 2022 May 16, 2022	SELL	$42.23 - $54.3 $10.8 Million - $13.8 Million	-255,013 Reduced 50.43%	250,690 $12.3 Million
Q4 2021 Feb 14, 2022	BUY	$50.62 - $56.47 $11.4 Million - $12.7 Million	225,359 Added 80.39%	505,703 $28.1 Million
Q3 2021 Nov 15, 2021	BUY	$46.55 - $56.83 $5.75 Million - $7.02 Million	123,446 Added 78.68%	280,344 $14.5 Million
Q2 2021 Aug 16, 2021	SELL	$46.28 - $52.75 $7.59 Million - $8.65 Million	-163,959 Reduced 51.1%	156,898 $7.59 Million
Q1 2021 May 17, 2021	SELL	$46.25 - $56.02 $11 Million - $13.4 Million	-238,714 Reduced 42.66%	320,857 $15.6 Million
Q4 2020 Feb 16, 2021	BUY	$46.09 - $54.74 $3.23 Million - $3.84 Million	70,141 Added 14.33%	559,571 $29.5 Million
Q3 2020 Nov 16, 2020	BUY	$42.51 - $52.42 $18.8 Million - $23.1 Million	441,127 Added 913.25%	489,430 $25.6 Million
Q2 2020 Aug 14, 2020	SELL	$39.49 - $44.36 $15.2 Million - $17.1 Million	-385,493 Reduced 88.87%	48,303 $2.07 Million
Q1 2020 May 15, 2020	SELL	$33.17 - $41.6 $19.4 Million - $24.3 Million	-585,125 Reduced 57.43%	433,796 $18 Million
Q4 2019 Feb 14, 2020	SELL	$25.41 - $43.1 $32.5 Million - $55.1 Million	-1,279,307 Reduced 55.66%	1,018,921 $34.4 Million
Q3 2019 Nov 14, 2019	BUY	$32.73 - $40.81 $3.38 Million - $4.21 Million	103,195 Added 4.7%	2,298,228 $75.8 Million
Q2 2019 Aug 14, 2019	BUY	$35.73 - $41.39 $17.4 Million - $20.2 Million	487,844 Added 28.58%	2,195,033 $89 Million
Q1 2019 May 15, 2019	SELL	$33.78 - $40.68 $1.66 Million - $2 Million	-49,087 Reduced 2.79%	1,707,189 $69.4 Million
Q4 2018 Feb 14, 2019	BUY	$32.65 - $37.95 $9.49 Million - $11 Million	290,673 Added 19.83%	1,756,276 $60.5 Million
Q3 2018 Nov 14, 2018	BUY	$35.99 - $39.39 $11.7 Million - $12.9 Million	326,411 Added 28.65%	1,465,603 $55.5 Million
Q2 2018 Aug 14, 2018	BUY	$31.23 - $37.47 $18.7 Million - $22.5 Million	600,026 Added 111.29%	1,139,192 $41.2 Million
Q1 2018 May 15, 2018	SELL	$31.01 - $34.72 $1.71 Million - $1.92 Million	-55,162 Reduced 9.28%	539,166 $17.4 Million
Q4 2017 Feb 14, 2018	SELL	$30.68 - $35.37 $8.76 Million - $10.1 Million	-285,380 Reduced 32.44%	594,328 $18.4 Million
Q3 2017 Nov 14, 2017	BUY	$31.02 - $32.94 $27.3 Million - $29 Million	879,708	879,708 $27.7 Million

Others Institutions Holding QGEN

# of Institutions

Shares Held

6.34M

Call Options Held

Put Options Held

Pendal Group LTD

4.3M
Shares

$187 Million
1.76% of portfolio
Abeille Asset Management Sa

931K
Shares

$40.6 Million
1.68% of portfolio
Grandeur Peak Global Advisors, LLC Salt Lake City, UT

768K
Shares

$33.4 Million
2.63% of portfolio
Pictet Asset Management Sa Geneva 73, V8

153K
Shares

$6.68 Million
0.01% of portfolio
Bdl Capital Management Paris, I0

88.8K
Shares

$3.87 Million
3.33% of portfolio

View Full List

About QIAGEN N.V.

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.92B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

More about QGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account